Floatz logo

281 assets in Gastric Cancer

Therapeutic assets addressing Gastric Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Osimertinib
Gastric Cancer
Merus B.V.P1/2CC (41)
Petosemtamab
Gastric Cancer
Merus B.V.P1/2CC (41)
Precemtabart Tocentecan
Gastric Cancer
EMD Serono Research & Development Institute, Inc.P1/2CC (41)
q702
Gastric Cancer
Qurient Co., Ltd.P1/2CC (41)
Regorafenib
Gastric Cancer
Neonc Technologies, Inc.P1/2CC (41)
Ropidoxuridine
Gastric Cancer
National Cancer Institute (NCI)P1CC (41)
Saruparib
Gastric Cancer
AstraZenecaP1/2CC (41)
Satricabtagene Autoleucel
Gastric Cancer
CARsgen Therapeutics Co., Ltd.P1/2CC (41)
sh009
Gastric Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd.P1CC (41)
Solnerstotug
Gastric Cancer
Sensei Biotherapeutics, Inc.P1/2CC (41)
Sysa1801 For
Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.P1CC (41)
Tak-500
Gastric Cancer
TakedaP1/2CC (41)
Tcr-T Cells
Gastric Cancer
Beijing Geekgene Technology Co., LTDP1/2CC (41)
th9619
Gastric Cancer
One-carbon Therapeutics ABP1/2CC (41)
The-0504
Gastric Cancer
Thena Biotech S.r.l.P1CC (41)
Tocilizumab
Gastric Cancer
TakedaP1/2CC (41)
tt-4
Gastric Cancer
Tarus Therapeutics, Inc.P1/2CC (41)
Vofatamab
Gastric Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
Vorbipiprant
Gastric Cancer
Rottapharm BiotechP1/2CC (41)
xh001
Gastric Cancer
Shenzhen Xinhe BiomedicalP1CC (41)
Adriamycin
Gastric Cancer
City of Hope Medical CenterP1CC (40)
Cabotamig
Gastric Cancer
Arbele Pty LtdP1CC (40)
Cb Car-Nk18.2
Gastric Cancer
Zhejiang Provincial People's HospitalP1CC (40)
Cdx-585
Gastric Cancer
Celldex TherapeuticsP1CC (40)
Cue-102
Gastric Cancer
Cue BiopharmaP1CC (40)
Imiquimod
Gastric Cancer
Toray Industries, IncP1CC (40)
NC 410
Gastric Cancer
NextCure, Inc.P1/2CC (40)
ro7496353
Gastric Cancer
Genentech, Inc.P1CC (40)
Zimberelimab
Gastric Cancer
Arcus Biosciences, Inc.P1CC (40)
177lu-dota-sna040
Gastric Cancer
SmartNuclide BiopharmaEarly P1C (39)
cdh17 car-t
Gastric Cancer
Zhejiang UniversityEarly P1C (39)
Fast Laco-Stim Cdh17 Car-T
Gastric Cancer
Zhejiang UniversityEarly P1C (39)
89zr-lncab072
Gastric Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (38)
89zr-lncab103
Gastric Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (38)
89zr-lncab104
Gastric Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (38)
89zr-lncab190
Gastric Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (38)
nk510
Gastric Cancer
Base Therapeutics (Shanghai) Co., Ltd.Early P1C (38)
[111in]-fpi-2058
Gastric Cancer
3B Pharmaceuticals GmbHP1C (37)
[111in]-fpi-2107
Gastric Cancer
AstraZenecaP1C (37)
1H-Isoindol-1-one, 2,3-dihydro-2-[3-[cis-3-methyl-1-(4-methyl-4H-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methyl-1-piperidinyl]methyl]-4-(trifluoromethyl)-
Gastric Cancer
Nurix Therapeutics, Inc.P1C (37)
[225ac]-fpi-2068
Gastric Cancer
AstraZenecaP1C (37)
[225]-fpi-2059
Gastric Cancer
3B Pharmaceuticals GmbHP1C (37)
(3RS)-1-(6-(.ALPHA.-METHYLPOLY(OXYETHYLENE)AMINO)-6-OXOHEXYL)-2,5-DIOXOPYRROLIDIN-3-YL)-L-CYSTEINAMIDE, (20000 MW)
Gastric Cancer
Lumicell, Inc.P1/2C (37)
ab598
Gastric Cancer
Arcus Biosciences, Inc.P1C (37)
ai-061
Gastric Cancer
OncoC4, Inc.P1C (37)
Apg-5918
Gastric Cancer
Ascentage Pharma Group Inc.P1C (37)
aur106
Gastric Cancer
Aurigene Discovery Technologies LimitedP1C (37)
Autologous Genetically Modified Mage-A4ᶜ¹º³²T Cells
Gastric Cancer
USWM CT, LLCP1C (37)
bal0891
Gastric Cancer
SillaJen, Inc.P1C (37)
bg-68501
Gastric Cancer
BeiGeneP1C (37)
Showing 151 to 200 of 281 assets
PreviousPage 4 of 6Next